October 16th 2024
The Sonire Therapeutics ultrasound system is currently being studied for the treatment of patients with unresectable pancreatic cancer refractory or intolerant to first-line chemotherapy.
Key Challenges with the O-RADS Ultrasound Classification System
July 27th 2022While the Ovarian-Adnexal Reporting and Data System ultrasound (O-RADS US) system provides a standardized and validated system for classification and risk stratification of ovarian and adnexal masses, a variety of clinical scenarios may prohibit or limit use of the system.
Eight Perspectives from Radiology Organizations on the Overturning of Roe v. Wade
July 2nd 2022In recently issued statements, different radiology organizations have offered perspectives on the physician-patient relationship and the potential impact of the Supreme Court’s decision to overturn Roe v. Wade.
Is Whole Body Imaging Warranted for Thrombocytopenia Caused by a COVID-19 Vaccine?
June 14th 2022In what may be the largest study to date to examine the use of whole-body imaging to assess multisystem thrombosis in patients with COVID-19 vaccine-induced immune thrombotic thrombocytopenia, researchers found multiple sites of thrombosis in 83 percent of patients who had additional CT, MRI and/or ultrasound imaging beyond the area of their primary complaint.
New Study Points to Longer Duration of Axillary Lymphadenopathy After COVID-19 Vaccine
May 20th 2022While COVID-19 vaccine clinical trials noted that post-vaccine axillary lymphadenopathy lasted for one to 10 days, emerging breast ultrasound research found a mean resolution of 127 days after a first vaccine dose.
Can Deep Learning Ultrasound Assessment be a Viable Option for Diagnosing Ovarian Cancer?
April 20th 2022A new study suggests that deep learning algorithms with multimodal ultrasound have comparable specificity and sensitivity to subjective expert assessment and use of the O-RADS classification to distinguish between benign and malignant ovarian tumors.
Is Handheld Ultrasound the 'New Stethoscope'?
March 2nd 2022In combination with cloud-based data infrastructure and artificial intelligence (AI) applications, handheld ultrasound devices may have the potential to significantly enhance efficiency for providers and contribute to improved patient outcomes.
Philips Expands Imaging Capabilities on Handheld Ultrasound Device
February 10th 2022In addition to newly added advances with hemodynamic assessment and obstetric measurements, Lumify also offers a B-line quantification tool and AI-enhanced algorithms that may bolster ultrasound lung imaging in severe COVID-19 cases.
COVID Vaccine Side Effects and Mammograms: What a New Study Reveals
February 8th 2022Emerging research suggests that mammograms should not be delayed for women who develop unilateral lymphadenopathy after receiving COVID-19 vaccines, and that follow-up imaging is unnecessary for patients who have no history of cancer or suspicious concurrent symptoms.